Trademark: 79284565
Word
CELLPROTHERA
Status Date
Tuesday, November 23, 2021
Registration Number
6564631
Registration Date
Tuesday, November 23, 2021
Filing Date
Wednesday, April 1, 2020
Published for Opposition
Tuesday, September 7, 2021
5 Biological preparations for cell cultures, cell culture media, culture media for cell growth for medical biotechnology, biological reagents for molecular biology, chemical reagents for medical use for biological processes, carriers of culture media for medical use, cellular function activating agents, serums, antibodies, all these products being for medical use
44 Services for medical care and treatment, namely therapeutic treatments in the field of cell therapy and regenerative medicine; medical services for cell growth, sampling and isolation for the production of cell and cell-derived human and animal cell products, namely, cell and stem cell graft injection therapy allowing for the regeneration of damaged tissues following age-related diseases or traumas for medical treatment services; services for medical analysis relating to treating individuals, namely, behavioral analysis for medical purposes, therapeutic treatment, namely cell therapy for regenerative medicine
10 Medical apparatus and instruments, namely, medical devices in the nature of human and animal cell, stem cells and cell-derived products and instruments for injection of cell, stem cells and cell-derived products, namely, chambers for culture, centrifugation and isolation of cell, stem cell and cell-derived for cell-based diagnosis and treatment; apparatus for cell culture, namely medical devices for human and animal cell culture diagnosis and treatment; medical instruments for cell culture, namely instruments for cell culture media and for potency testing of human and animal cell and cell-derived products for cell based treatment and diagnostic; medical apparatus and devices for cell separation techniques, namely, medical device and apparatus for human and animal cell selection, for human cell immune and for cell dimension selection for the cell-based diagnosis and treatment
42 Research and development services of new products in the field of biotechnology, scientific analysis services in the field of medical research laboratory services for medical purposes and for development of new products for medical research for third parties
The mark consists of the stylized wording "CELLPROTHERA" and the letter "O" is completely shaded.
Color is not claimed as a feature of the mark.
The wording "CELLPROTHERA" has no meaning in a foreign language.
May 30, 2022
Final Decision Transaction Processed By Ib
May 10, 2022
Final Disposition Notice Sent To Ib
May 10, 2022
Final Disposition Processed
Feb 23, 2022
Final Disposition Notice Created, To Be Sent To Ib
Nov 23, 2021
Registered-Principal Register
Oct 29, 2021
Notification Of Possible Opposition - Processed By Ib
Oct 6, 2021
Notification Of Possible Opposition Sent To Ib
Oct 6, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Sep 4, 2021
Notification Processed By Ib
Aug 18, 2021
Notification Of Possible Opposition Sent To Ib
Aug 18, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Jul 30, 2021
Approved For Pub - Principal Register
Jul 21, 2021
Teas/Email Correspondence Entered
Jul 21, 2021
Correspondence Received In Law Office
Jul 21, 2021
Teas Request For Reconsideration Received
Mar 8, 2021
Notification Of Final Refusal Emailed
Mar 8, 2021
Final Refusal E-Mailed
Mar 8, 2021
Final Refusal Written
Jan 27, 2021
Teas/Email Correspondence Entered
Jan 27, 2021
Correspondence Received In Law Office
Jan 27, 2021
Teas Response To Office Action Received
Aug 29, 2020
Refusal Processed By Ib
Aug 4, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Aug 4, 2020
Refusal Processed By Mpu
Jun 29, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jun 28, 2020
Non-Final Action Written
Jun 21, 2020
Assigned To Examiner
May 7, 2020
Application Filing Receipt Mailed
May 3, 2020
New Application Office Supplied Data Entered In Tram
Apr 30, 2020
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
